CD28 and neoplasm: In addition to costimulatory signals like CD28 and (or) 4-1BB, the so-called fourth generation of CAR-T cells were also equipped with a nuclear factor of activated T cell-responsive expression element to overcome the immunosuppressive tumor microenvironment, such as PD1 inhibitor, IL-12 or IL-15 (12–14).